Skip to main content
. 2025 Sep 12;14(18):6445. doi: 10.3390/jcm14186445
ACC American College of Cardiology
ACS Acute Coronary Syndrome
AHA American Heart Association
ASCVD Atherosclerotic Cardiovascular Disease
BMI Body Mass Index
BP Blood Pressure
CAD Coronary Artery Disease
CI Confidence Interval
CRP C-Reactive Protein
CV Cardiovascular
CVD Cardiovascular Disease
DASH Dietary Approaches to Stop Hypertension
DM Diabetes Mellitus
ESC European Society of Cardiology
EVOPACS Evolocumab for Early Reduction in LDL cholesterol levels in Patients With Acute Coronary Syndromes
FPP Farnesyl Pyrophosphate
HDL High-Density Lipoprotein
HDL-C High-Density Lipoprotein Cholesterol
HMG-CoA Hydroxymethylglutaryl-Coenzyme A
HR Hazard Ratio
IPE Icosapent Ethyl
LCBI Lipid Core Burden Index
LDL Low-Density Lipoprotein
LDL-C Low-Density Lipoprotein Cholesterol
LLT Lipid-Lowering Therapy
MACE Major Adverse Cardiovascular Events
MI Myocardial Infarction
NIRS Near-Infrared Spectroscopy
NSTEMI Non-ST-Elevation Myocardial Infarction
OCT Optical Coherence Tomography
OR Odds Ratio
PACT Pravastatin in Acute Coronary Treatment
PCI Percutaneous Coronary Intervention
PCSK9 Proprotein Convertase Subtilisin/Kexin Type 9
RCT Randomized Controlled Trial
RR Relative Risk
STEMI ST-Elevation Myocardial Infarction
SWEDEHEART Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies
TG Triglycerides
UA Unstable Angina
VLDL Very-Low-Density Lipoprotein
hs-CRP High-Sensitivity C-Reactive Protein
siRNA Small Interfering Ribonucleic Acid